metastatic breast cancerpyrotinibtrastuzumabdocetaxel
…proving overall survival for initial treatment of HER2 positive metastatic breast cancer. The safety profile remained consistent with interim findings, …
10articles mentioning diseases
13disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: metastatic breast cancer ×
metastatic breast cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning metastatic breast cancer
10 articles · page 1 of 195.0%
non-small cell lung cancermetastatic breast cancerOral Lichen Planus (OLP)DifflamGlasgow Dental HospitalZoledronic acidbenzydaminesodium lauryl sulphatechemotherapyimmunotherapy
…spital. One patient had metastatic breast cancer; the other had non-small cell lung cancer.Results Patient A, on immunotherapy for metastatic breast cance…
colitismetastatic melanomametastatic breast cancerpembrolizumabInfliximabUniversity Hospital Coventryipilimumabnivolumaboxaliplatin
… management of ICI-induced enterocolitis, immunotherapy-related colitis remains a relatively new clinical entity that presents ongoing …
NSCLCmCRCCRCBCnon-small cell lung cancersnon-small cell lung cancer
…I; and the American Lung Association and Lung Cancer Europe for NSCLC. Selection of patient-advocacy organisations was guided by thre…
HER2-positive metastatic breast cancermetastatic breast cancerHER2-low metastatic breast cancerHER2-low diseaseunresectable or metastatic breast cancerHER2-low unresectable or metastatic breast cancerHER2-positive unresectable or metastatic breast cancerHER2-positive diseaseT-DXdTrastuzumab deruxtecan
…n (T-DXd) is an antibody–drug conjugate with proven efficacy in HER2-positive metastatic breast cancer and, more recently, in HER2-low disease. However, real-world da…
breast cancermetastatic breast cancersacituzumab govitecanirinotecanirinotecan-treatedLGC Genomics1000 Genomes ProjectApplied Biosystems
…ovitecan is an antibody–drug conjugate indicated for metastatic breast cancer, whose active metabolite is SN-38. Like irinotecan, this metabo…
Erdheim–Chester diseasemetastatic breast cancer
…: one revealing metastatic breast cancer and another confirming Erdheim–Chester disease. Both procedures were completed without complications and allow…
metastatic breast cancerMBC
…Objectives Time is crucial for patients with metastatic breast cancer (MBC), and clinicians are expected to determine the optimal tim…
HER2-low breast cancerHER2-low tumorshuman breast cancermetastatic breast cancerTrastuzumab deruxtecantrastuzumab-deruxtecantrastuzumabU of North TexasTrastuzumab-based treatments
… using SE-NK/Tz cells as a novel immunotherapeutic approach for HER2-low breast cancer. Our preliminary findings confirmed the targeted nature of this…
Metastatic Breast CancerEBCmetastatic diseaseimmunotherapies
…Background Metastatic Breast Cancer (MBC) poses a significant clinical challenge where immunotherap…